Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck

Cancer testis antigens (CTAs) are T‐cell–defined tumor‐associated antigens encoded by the genes and gene families such as MAGE, NY‐ESO‐1, and others. Their expression in a wide variety of malignant neoplasms but absence in all normal adult tissue except testicular germ cells makes them attractive targets for immunotherapy of cancer. Primary mucosal melanomas of the head and neck (HNMM) are rare aggressive malignant tumors that are usually difficult to treat. CTAs may provide useful targets for therapy; however, their expression in HNMM is not known.

[1]  L. Old,et al.  Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes , 2004, Immunogenetics.

[2]  T. Sakurai,et al.  MAGE-A4 Interacts with the Liver Oncoprotein Gankyrin and Suppresses Its Tumorigenic Activity* , 2003, Journal of Biological Chemistry.

[3]  S. Aamdal,et al.  Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. , 2003, European journal of cancer.

[4]  Yao-Tseng Chen,et al.  Cancer/testis antigens: an expanding family of targets for cancer immunotherapy , 2002, Immunological reviews.

[5]  G. Sauter,et al.  Prognostic relevance of MAGE‐A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study , 2002, International journal of cancer.

[6]  Yao-Tseng Chen,et al.  CT7 (MAGE‐C1) antigen expression in normal and neoplastic tissues , 2002, International journal of cancer.

[7]  D. Jäger,et al.  Clinical cancer vaccine trials. , 2002, Current opinion in immunology.

[8]  J. Shah,et al.  Primary mucosal malignant melanoma of the head and neck , 2002, Head & neck.

[9]  N. Altorki,et al.  Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues , 2001, International journal of cancer.

[10]  D. Jäger,et al.  Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Coulie,et al.  Monoclonal antibody 57B stains tumor tissues that express gene MAGE‐A4 , 2000, International journal of cancer.

[12]  L. Old,et al.  Immunoreactivity with the Anti-MAGE Antibody 57B in Malignant Melanoma: Frequency of Expression and Correlation with Prognostic Parameters , 2000, Modern Pathology.

[13]  Yao-Tseng Chen,et al.  Expression of MAGE‐antigens in normal tissues and cancer , 2000, International journal of cancer.

[14]  L. Terracciano,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0810 Expression of MAGE-1 and-3 genes and gene products in human hepatocellular carcinoma , 2022 .

[15]  P. Coulie,et al.  Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1 , 1999, International journal of cancer.

[16]  Yao-Tseng Chen,et al.  Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies , 1998, International journal of cancer.

[17]  L. Karnell,et al.  The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.

[18]  Lloyd J. Old,et al.  A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.

[19]  Yao-Tseng Chen,et al.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. van der Bruggen,et al.  T cell defined tumor antigens. , 1997, Current opinion in immunology.

[21]  F. Garrido,et al.  Methylated CpG points identified within MAGE‐1 promoter are involved in gene repression , 1996, International journal of cancer.

[22]  O. de Backer,et al.  The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Rika Deraemaecker,et al.  Expression of MAGE genes in primary and metastatic cutaneous melanoma , 1995, International journal of cancer.

[24]  O. de Backer,et al.  A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma , 1995, The Journal of experimental medicine.

[25]  F. Gudat,et al.  Identification and intracellular location of MAGE-3 gene product. , 1995, Cancer research.

[26]  R. Brasseur,et al.  BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. , 1995, Immunity.

[27]  P. Chomez,et al.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.

[28]  Daan Brandenbarg The National. , 1892 .